105 related articles for article (PubMed ID: 30502451)
1. Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin.
Godoy ALPC; de Moraes NV; Benzi JRL; Lanchote VL
Eur J Pharm Sci; 2019 Feb; 128():97-102. PubMed ID: 30502451
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol enantiomers in rat plasma by high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics.
Godoy AL; De Moraes NV; Martinez EZ; Carvalho TM; Marques MP; Lanchote VL
Chirality; 2011 Apr; 23(4):287-93. PubMed ID: 21384434
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype.
García-Quetglas E; Azanza JR; Sádaba B; Muñoz MJ; Gil I; Campanero MA
Pharmacol Res; 2007 Feb; 55(2):122-30. PubMed ID: 17175164
[TBL] [Abstract][Full Text] [Related]
4. Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers.
de Moraes NV; Lauretti GR; Lanchote VL
J Pharm Pharmacol; 2014 Sep; 66(9):1222-30. PubMed ID: 24717054
[TBL] [Abstract][Full Text] [Related]
5. Gender-related differences in pharmacokinetics of enantiomers of trans-tramadol and its active metabolite, trans-O-demethyltramadol, in rats.
Liu HC; Jin SM; Wang YL
Acta Pharmacol Sin; 2003 Dec; 24(12):1265-9. PubMed ID: 14653955
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the route dependency of the pharmacokinetics and neuro-pharmacokinetics of tramadol and its main metabolites in rats.
Sheikholeslami B; Gholami M; Lavasani H; Rouini M
Eur J Pharm Sci; 2016 Sep; 92():55-63. PubMed ID: 27365222
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of enantiomers of trans-tramadol and its active metabolite, trans-O-demethyltramadol, in human subjects.
Liu HC; Liu TJ; Yang YY; Hou YN
Acta Pharmacol Sin; 2001 Jan; 22(1):91-6. PubMed ID: 11730570
[TBL] [Abstract][Full Text] [Related]
8. [Stereoselectivity in biliary excretion of trans tramadol and trans O-demethyltramadol in rats].
Liu HC; Yu Y; Wang N; Hou YN; Wang YL
Yao Xue Xue Bao; 2003 Jun; 38(6):412-5. PubMed ID: 14513798
[TBL] [Abstract][Full Text] [Related]
9. Enantioselective pharmacokinetics of tramadol and its three main metabolites; impact of
Haage P; Kronstrand R; Josefsson M; Calistri S; van Schaik RHN; Green H; Kugelberg FC
Pharmacol Res Perspect; 2018 Jul; 6(4):e00419. PubMed ID: 29992026
[TBL] [Abstract][Full Text] [Related]
10. Enantioselective analysis of unbound tramadol, O-desmethyltramadol and N-desmethyltramadol in plasma by ultrafiltration and LC-MS/MS: application to clinical pharmacokinetics.
de Moraes NV; Lauretti GR; Napolitano MN; Santos NR; Godoy AL; Lanchote VL
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 880(1):140-7. PubMed ID: 22173007
[TBL] [Abstract][Full Text] [Related]
11. [Transportation of the enantiomers of trans tramadol and O-demethyltramadol across blood-brain barrier].
Liu HC; Hu YQ; Liu JF; Wang N; Hou YN
Yao Xue Xue Bao; 2001 Sep; 36(9):644-7. PubMed ID: 12580098
[TBL] [Abstract][Full Text] [Related]
12. Route-dependent stereoselective pharmacokinetics of tramadol and its active O-demethylated metabolite in rats.
Parasrampuria R; Vuppugalla R; Elliott K; Mehvar R
Chirality; 2007 Mar; 19(3):190-6. PubMed ID: 17192836
[TBL] [Abstract][Full Text] [Related]
13. Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6-Mediated Drug-Drug Interactions on Tramadol and O-Desmethyltramadol Exposures via Allosteric and Competitive Inhibition.
Long T; Cristofoletti R; Cicali B; Michaud V; Dow P; Turgeon J; Schmidt S
J Clin Pharmacol; 2022 Jan; 62(1):76-86. PubMed ID: 34383318
[TBL] [Abstract][Full Text] [Related]
14. Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers.
Pedersen RS; Damkier P; Brøsen K
Eur J Clin Pharmacol; 2006 Jul; 62(7):513-21. PubMed ID: 16763825
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of tramadol and its three main metabolites in healthy male and female volunteers.
Ardakani YH; Rouini MR
Biopharm Drug Dispos; 2007 Dec; 28(9):527-34. PubMed ID: 17891748
[TBL] [Abstract][Full Text] [Related]
16. [Gender-related differences in metabolism of the enantiomers of trans tramadol and trans O-demethyltramadol in rat liver microsomes].
Jin SM; Liu HC
Yao Xue Xue Bao; 2004 Aug; 39(8):581-5. PubMed ID: 15563056
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic/pharmacodynamic modeling of the antinociceptive effects of (+)-tramadol in the rat: role of cytochrome P450 2D activity.
Garrido MJ; Sayar O; Segura C; Rapado J; Dios-Vieitez MC; Renedo MJ; Troconiz IF
J Pharmacol Exp Ther; 2003 May; 305(2):710-8. PubMed ID: 12606644
[TBL] [Abstract][Full Text] [Related]
18. Identification of canine cytochrome P-450s (CYPs) metabolizing the tramadol (+)-M1 and (+)-M2 metabolites to the tramadol (+)-M5 metabolite in dog liver microsomes.
Perez Jimenez TE; Mealey KL; Schnider D; Grubb TL; Greene SA; Court MH
J Vet Pharmacol Ther; 2018 Dec; 41(6):815-824. PubMed ID: 30113702
[TBL] [Abstract][Full Text] [Related]
19. Influence of Obesity and Type 2 Diabetes Mellitus on the Pharmacokinetics of Tramadol After Single Oral Dose Administration.
Porażka J; Szałek E; Połom W; Czajkowski M; Grabowski T; Matuszewski M; Grześkowiak E
Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):579-584. PubMed ID: 30778911
[TBL] [Abstract][Full Text] [Related]
20. Stereoselectivity in trans-tramadol metabolism and trans-O-demethyltramadol formation in rat liver microsomes.
Liu HC; Wang N; Yu Y; Hou YN
Acta Pharmacol Sin; 2003 Jan; 24(1):85-90. PubMed ID: 12511234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
